Starting January 1, 2018, The DOT, Department of Transportation, began requiring testing for four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone).
Like the DOT, many organizations are trying to combat the effects of opioid abuse at work through testing such as reasonable suspicion (for cause) and post-incident drug testing, as well as recurrent testing, i.e. random monthly drug tests.
Keep in mind though, many standard 5- and even 10-panel tests don’t screen for many common opioid-related prescription drugs. It’s something you may need to ask your testing provider to include.